Northern Alliance ATTC

Northern Alliance Advanced Therapies Treatment Centre - accelerating access to Advanced Therapies

[Northern Alliance ATTC @naattc]

We are delighted to share that the ATTC Network, co-ordinated by the CGT Catapult has received funding from the NIHR. This funding will allow continuation and enhancement of advanced therapy clinical trial initiatives. Here is the full story:
https://t.co/TIBCuOfSJb

[Northern Alliance ATTC @naattc]

Don’t miss this upcoming webinar hosted by the ATTC network on the 24 January 2024 at 1600 ‘Evaluation of the patient referral pathways for gene therapy and CAR-T in the UK’. Register here https://t.co/A21i8cGn3j

[Northern Alliance ATTC @naattc]

In order to remain a life-sciences ‘superpower’ the UK needs to act now.
The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. https://t.co/zqPHGTa3w1

#CellandGeneTherapy #AdvancedTherapies

[Northern Alliance ATTC @naattc]

Doing nothing is not an option in the field of Advanced Therapies. This report describes how the UK can retain its lead in the field. https://t.co/zqPHGTaBlz #CellandGeneTherapy #AdvancedTherapies

[Northern Alliance ATTC @naattc]

In Oct influential, knowledgeable and experienced minds met
@RoySocMed in London to discuss barriers and develop solutions to the UK Advanced Therapies Adoption Challenge Read the report https://t.co/zqPHGTa3w1

[Northern Alliance ATTC @naattc]

In order to remain a life-sciences ‘superpower’ the UK needs to act now.
The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. https://t.co/zqPHGTaBlz

[Northern Alliance ATTC @naattc]

The future of access for patients to life changing advanced therapies lies in the hands of policy-makers and, in order to remain a life-sciences ‘superpower’, the UK needs to act now. https://t.co/H9UhWqZKDw
#CellandGeneTherapy #AdvancedTherapies

[Northern Alliance ATTC @naattc]

ATMP Engage: ensuring patients are at the heart of ATMP delivery and research - register below for this webinar next Wed 8/12/23 hosted by the ATTC network.

https://t.co/UgovnfocWW

[Northern Alliance ATTC @naattc]

@NewcastleHosps adopted a new labelling process (ISBT 128) in order to meet the most recent standards for apheresis products. https://t.co/KdzzlJjQmr

[Northern Alliance ATTC @naattc]

We have concluded a joint, successful project with the DMD Hub (@UniofNewcastle) and the @CGTCatapult, which has resulted in a publication that analyses the gene therapy patient referral pathways in the UK.
https://t.co/hstl3lRTwy

[Incisive Health @incisivehealth]

Excited to be attending the 25th Communiqué awards with our clients @alderhey @CGTCatapult @GileadSciences. Good luck to all the finalists! @CxHealth #cxhealth

[Northern Alliance ATTC @naattc]

@UniofNewcastle will lead the administrative hub for this UK rare disease research platform, as well as being involved in two of the eleven nodes. Exciting opportunity for all involved.

[National Institute for Health and Care Research @NIHRresearch]

The NIHR and @The_MRC are co-funding a new £14m UK Rare Disease Research Platform.

It will help to overcome some of the most common challenges in the diagnosis, management and treatment of #RareDiseases

https://t.co/lOQtRBP4ml

[Northern Alliance ATTC @naattc]

@jwmdrc

[Northern Alliance ATTC @naattc]

Exciting to be part of this day run by the DMD Hub in Newcastle, looking at and agreeing the structure of gene therapy patient referral pathways.

[Northern Alliance ATTC @naattc]

Read all about the survey results led by our partner Autolus. The analysis looks at and evaluates the current landscape for electronic cell orchestration platforms.
https://t.co/eLJoBuKusd

[Northern Alliance ATTC @naattc]

Future best practice recommendations coming soon for CAR-T patient referral pathways
https://t.co/EVXcKKInse

[Scot Gov Health @scotgovhealth]

Health Secretary @MathesonMichael has opened a new laboratory for cutting-edge work into potentially life-saving gene therapies in Edinburgh BioQuarter.

The innovative work led @CGTCatapult will help ensure our healthcare systems are prepared for the future.

[iMATCH-ATTC @iMATCH_ATTC]

*New Publication* from our University of Manchester iMATCH team 🐝
Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy 👉 https://t.co/3PirgZzRmU

[Sarepta Therapeutics @Sarepta]

NEWS: SRPT today shared a program update related to SRP-9001. Read our press release:
https://t.co/ateY4r8U5E

[Northern Alliance ATTC @naattc]

Our partners @Cytiva and @NHSBT have produced a document comparing liquid nitrogen and liquid nitrogen free controlled-rate freezing for the cryopreservation of MSCs.
https://t.co/LOeHuMmXpO